COVID-19 Persistence in Stool
NCT04546776 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105
Last updated 2025-06-17
Summary
This is a longitudinal study in which participants that have been confirmed by a National Health Service (NHS) swab test as COVID-19 positive will be asked to provide faecal and saliva samples, and complete short health/lifestyle questionnaires at the time of sampling (referred to as a sample set). The number of sample sets collected from any participant will be dependent on how long the SARS-CoV-2 virus persists within the stool. The investigators aim to collect a minimum of 4 and a maximum of 8 sample sets, and will target all COVID-19-positive subjects, with the exception of those severally ill (e.g. in the intensive care unit (ICU)). The investigators aim to recruit a minimum of 100 and up to 200 participants. To obtain the desired numbers, it may be necessary to continue recruitment during any further United Kingdom (UK) COVID-19 infection peaks.
Conditions
- SARS-CoV Infection
Sponsors & Collaborators
-
Norfolk and Norwich University Hospitals NHS Foundation Trust
collaborator OTHER -
James Paget University Hospital NHS Foundation Trust
collaborator OTHER -
Quadram Institute Bioscience
lead OTHER
Principal Investigators
-
Arjan Narbad, BSc, PhD · Quadram Institute Bioscience
-
Ngozi Franslem-Elumogo, MBBS, DTM&H, FRCPath · Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
-
Andreas Brodbeck, PhD, FRCA, FICM · James Paget University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-08
- Primary Completion
- 2024-11-30
- Completion
- 2025-05-09
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Association of Gut Microbiota With COVID 19 Infection in Children
NCT05303155 ·Status: UNKNOWN
-
Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings
NCT05794620 ·Status: COMPLETED
-
Stool Collection for Model
NCT06988514 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France
NCT04325646 ·Status: COMPLETED
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
NCT04359836 ·Status: RECRUITING
-
COVID-19 and Intestinal Microbiota in Children
NCT06503887 ·Status: COMPLETED
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Effects of Intravenous (IV) Omadacycline on Gut Microbiome
NCT05515562 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of the Detection Rate of Pathogenic Viruses in the Feces of Individuals With Non-gastrointestinal Infections
NCT06367647 ·Status: RECRUITING
-
Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections
NCT01946750 ·Status: COMPLETED ·Phase: NA
-
Ursodeoxycholic Acid in C. Difficile Infection
NCT05526807 ·Status: TERMINATED ·Phase: NA
-
Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant
NCT02694484 ·Status: COMPLETED ·Phase: NA
-
Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress
NCT04443075 ·Status: COMPLETED
-
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
NCT03117582 ·Status: COMPLETED
-
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
NCT04335084 ·Status: COMPLETED ·Phase: PHASE2
-
Stools and Life Habits Collection in Heathy Volunteers/Subjects - to Provide Material for in Vitro Model Development
NCT04301973 ·Status: COMPLETED ·Phase: NA
-
Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection
NCT04960306 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The QIB Colon Model
NCT02653001 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Gut Microbiota, "Spark and Flame" of COVID-19 Disease
NCT04355741 ·Status: COMPLETED
-
Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea
NCT04567134 ·Status: UNKNOWN
-
FMT in Initial CDI
NCT05257538 ·Status: RECRUITING ·Phase: NA
-
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
NCT03497806 ·Status: COMPLETED ·Phase: PHASE2
-
NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
NCT04540406 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT02052726 ·Status: COMPLETED ·Phase: PHASE1